{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:02:16Z","timestamp":1779296536507,"version":"3.51.4"},"reference-count":78,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therap Adv Gastroenterol"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> Biological therapy has revolutionized the treatment of inflammatory bowel disease (IBD). After the expiration of patents for biological innovator products, development of biosimilars increased. CT-P13 was the first biosimilar approved for the same indications as the reference product; however, the approval was based on extrapolated data from rheumatoid arthritis and ankylosing spondylitis. Our aim was to review clinical studies about switching from originator infliximab (IFX-O) to biosimilar infliximab (IXF-B) in IBD, focusing on recently published data and the future of biosimilars. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> The PubMed database was searched for original articles published up to 1 December 2018 reporting data on IFX-B in IBD. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> A total of 29 studies assessing switching from IFX-O to IFX-B, 14 assessing induction therapy with IFX-B were found. Efficacy, safety and immunogenicity were discussed. Studies confirm that CT-P13 is safe and equally efficient as the reference product for both induction and maintenance therapy; and that switching from the reference product to biosimilar is non-inferior to continuous biosimilar use. However, efficacy and safety data on Flixabi (SB2) in IBD patients is lacking. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p> Switching from the originator to a biosimilar in patients with IBD is acceptable, although scientific and clinical evidence is lacking regarding reverse switching, multiple switching and cross-switching among biosimilars in IBD patients. <\/jats:p><\/jats:sec>","DOI":"10.1177\/1756284819842748","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T06:26:57Z","timestamp":1555396017000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":29,"title":["Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective"],"prefix":"10.1177","volume":"12","author":[{"given":"\u00c1gnes","family":"Milassin","sequence":"first","affiliation":[{"name":"First Department of Medicine, University of Szeged, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"F\u00e1bi\u00e1n","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University of Szeged, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Moln\u00e1r","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University of Szeged, 6720 Szeged, Kor\u00e1nyi fasor 8\u201310, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"bibr1-1756284819842748","first-page":"1","volume":"44","author":"European Medicines Agency","year":"2013","journal-title":"Inflectra Assess Rep"},{"key":"bibr2-1756284819842748","first-page":"1","volume":"44","author":"European Medicines Agency","year":"2013","journal-title":"Remsima Assess Rep"},{"key":"bibr3-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"bibr4-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"bibr5-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"bibr6-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.155812"},{"key":"bibr7-1756284819842748","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.2544"},{"key":"bibr8-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.12.013"},{"key":"bibr9-1756284819842748","unstructured":"CHMP. Guideline on similar biological medicinal products, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/10\/WC500176768.pdf (2014, accessed 14 December 2017)."},{"key":"bibr10-1756284819842748","unstructured":"Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Guidance for Industry, http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm (2015, accessed 14 December 2017)."},{"key":"bibr11-1756284819842748","unstructured":"Committee for Medicinal Products. Flixabi \u2013 infliximab, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion_-_Initial_authorisation\/human\/004020\/WC500203991.pdf (accessed 14 December 2017)."},{"key":"bibr12-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-015-0150-5"},{"key":"bibr13-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207764"},{"key":"bibr14-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex254"},{"key":"bibr15-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211741"},{"key":"bibr16-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-011-0196-3"},{"key":"bibr17-1756284819842748","first-page":"119","volume":"16","author":"Brodszky V","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"bibr18-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2017.1322509"},{"key":"bibr19-1756284819842748","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170406112304."},{"key":"bibr20-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw153"},{"key":"bibr21-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.03.011"},{"key":"bibr22-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14453."},{"key":"bibr23-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000953"},{"key":"bibr24-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30068-5"},{"key":"bibr25-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv233"},{"key":"bibr26-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4661-4"},{"key":"bibr27-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1369561"},{"key":"bibr28-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2017.07.005"},{"key":"bibr29-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000995"},{"key":"bibr30-1756284819842748","first-page":"297","volume":"11","author":"Buer LCT","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"bibr31-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw087"},{"key":"bibr32-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1159\/000449088"},{"key":"bibr33-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X16650155"},{"key":"bibr34-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1159\/000453343"},{"key":"bibr35-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12997"},{"key":"bibr36-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210742"},{"key":"bibr37-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4511-4"},{"key":"bibr38-1756284819842748","first-page":"690","volume":"11","author":"Razanskaite V","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"bibr39-1756284819842748","first-page":"313","volume":"53","author":"Tursi A","year":"2017","journal-title":"Minerva Gastroenterol Dietol"},{"key":"bibr40-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.002"},{"key":"bibr41-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx047"},{"key":"bibr42-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30082-7"},{"key":"bibr43-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2018.1464203"},{"key":"bibr44-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001113"},{"key":"bibr45-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818801244"},{"key":"bibr46-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy264."},{"key":"bibr47-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002091"},{"key":"bibr48-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy227."},{"key":"bibr49-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2018.1463391"},{"key":"bibr50-1756284819842748","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2018.5368\/2017"},{"key":"bibr51-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091309"},{"key":"bibr52-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313404"},{"key":"bibr53-1756284819842748","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2017.70468"},{"key":"bibr54-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002011"},{"key":"bibr55-1756284819842748","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2016.1149883"},{"key":"bibr56-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw085"},{"key":"bibr57-1756284819842748","first-page":"1325","volume":"17","author":"Farkas K","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"bibr58-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1064893"},{"key":"bibr59-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091308"},{"key":"bibr60-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv220"},{"key":"bibr61-1756284819842748","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.1.5.9630"},{"key":"bibr62-1756284819842748","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.32221"},{"key":"bibr63-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"bibr64-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"bibr65-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208786"},{"key":"bibr66-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208783"},{"key":"bibr67-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309290"},{"key":"bibr68-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208684"},{"key":"bibr69-1756284819842748","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ecco-jcc\/jjx002.747","volume":"11","author":"Gonczi L","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"bibr70-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14262"},{"key":"bibr71-1756284819842748","doi-asserted-by":"publisher","DOI":"10.4172\/1948-593X.1000091"},{"key":"bibr72-1756284819842748","unstructured":"Casadevall N. Immune-response and adverse reactions: PRCA case example, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Presentation\/2009\/11\/WC500011064.pdf (2007, accessed 3 May 2018)."},{"key":"bibr73-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13990"},{"key":"bibr74-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0193-2"},{"key":"bibr75-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3392-z"},{"key":"bibr76-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14605"},{"key":"bibr77-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.155"},{"key":"bibr78-1756284819842748","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.06.007"}],"container-title":["Therapeutic Advances in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756284819842748","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1756284819842748","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1756284819842748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T03:44:19Z","timestamp":1740973459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1756284819842748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":78,"alternative-id":["10.1177\/1756284819842748"],"URL":"https:\/\/doi.org\/10.1177\/1756284819842748","relation":{},"ISSN":["1756-2848","1756-2848"],"issn-type":[{"value":"1756-2848","type":"print"},{"value":"1756-2848","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"article-number":"1756284819842748"}}